About Kim Patrick
Form D filings for Eumentis Therapeutics from 2023 to 2024 list Kim Patrick as director.
Kim Patrick first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Kim Patrick in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kim Patrick works with at each company, as listed on that company's latest Form D.
Eumentis Therapeutics, Inc. · Form D, Jun 26, 2024
MB
Maryann Bryla
Director
JL
James Larrick
Director
RM
Randall Marshall
Executive officer
MT
Mark Tepper
President and director
AP
Andrew Pearlman
Director